Regeneron Pharmaceuticals has recently launched a Phase 2 trial, testing the waters with a potential breakthrough in melanoma ...

Barclays recently nudged its Airbnb price target up a smidge, but still maintains an "Underweight" rating, suggesting ...

TJX Companies is catching the eyes of some pretty big investment firms, signaling confidence in the discount retail giant.

Mondelez International, Inc. has been a hot topic among analysts, with recent stock adjustments and investor moves creating ...

The crafty world of Etsy just got a bit more interesting as the Bank of New York Mellon Corp trimmed its Etsy holdings by 4.6 ...

Analog Devices (ADI) is showing financial strength. Analysts predict an upcoming EPS of $1.93, representing a 22.15% year-over-year increase. Revenue is also expected to climb to $2.76 billion, a ...

Lockheed Martin (LMT) is set to announce its Q2 2025 earnings before the market opens on Tuesday, with expectations set at $6.57 per share and revenue predictions at $18.59 billion. The aerospace ...

Starbucks, the ubiquitous coffee giant, has seen some interesting movement in its stock lately. Pittenger & Anderson Inc.

Deere & Company is plowing ahead as a favorite among institutional investors. The New York State Common Retirement Fund increased its stake, joining a herd of other funds loading up on the agriculture ...

Morgan Stanley has its eyes set on Bristol Myers Squibb's upcoming Phase 3 data for Cobenfy, a drug currently approved for ...

Headquartered in Bloomfield, Cigna (CI), a standout in the Medical HMOs sector, offers a promising dividend yield of 2%, ...

Marsh & McLennan Companies, Inc. (NYSE:MMC) experienced a slight portfolio trim as Fulton Breakefield Broenniman LLC sold ...